Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer

被引:9
作者
Miao, Junjie
Yan, Hui
Tian, Yuan
Ma, Pan
Liu, Zhiqiang
Li, Minghui
Ren, Wenting
Chen, Jiayun
Zhang, Ye
Dai, Jianrong [1 ]
机构
[1] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol, Beijing, Peoples R China
来源
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS | 2017年 / 18卷 / 06期
基金
中国国家自然科学基金;
关键词
IMRT; non small cell lung cancer; plan optimization; target dose homogeneity; treatment planning; INTENSITY-MODULATED RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; TUMOR-CONTROL PROBABILITY; RADIATION PNEUMONITIS; NSCLC PATIENTS; IMRT; VOLUME; THERAPY; DISTRIBUTIONS; PARAMETERS;
D O I
10.1002/acm2.12200
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
It is important to minimize lung dose during intensity-modulated radiation therapy (IMRT) of nonsmall cell lung cancer (NSCLC). In this study, an approach was proposed to reduce lung dose by relaxing the constraint of target dose homogeneity during treatment planning of IMRT. Ten NSCLC patients with lung tumor on the right side were selected. The total dose for planning target volume (PTV) was 60 Gy (2 Gy/fraction). For each patient, two IMRT plans with six beams were created in Pinnacle treatment planning system. The dose homogeneity of target was controlled by constraints on the maximum and uniform doses of target volume. One IMRT plan was made with homogeneous target dose (the resulting target dose was within 95%-107% of the prescribed dose), while another IMRT plan was made with inhomogeneous target dose (the resulting target dose was more than 95% of the prescribed dose). During plan optimization, the dose of cord and heart in two types of IMRT plans were kept nearly the same. The doses of lungs, PTV and organs at risk (OARs) between two types of IMRT plans were compared and analyzed quantitatively. For all patients, the lung dose was decreased in the IMRT plans with inhomogeneous target dose. On average, the mean dose, V5, V20, and V30 of lung were reduced by 1.4 Gy, 4.8%, 3.7%, and 1.7%, respectively, and the dose to normal tissue was also reduced. These reductions in DVH values were all statistically significant (P < 0.05). There were no significant differences between the two IMRT plans on V25, V30, V40, V50 and mean dose for heart. The maximum doses of cords in two type IMRT plans were nearly the same. IMRT plans with inhomogeneous target dose could protect lungs better and may be considered as a choice for treating NSCLC.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
[41]   Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer [J].
Low, Jia Li ;
Huang, Yiqing ;
Sooi, Kenneth ;
Ang, Yvonne ;
Chan, Zhi Yao ;
Spencer, Katie ;
Jeyasekharan, Anand Devaprasath ;
Sundar, Raghav ;
Goh, Boon Cher ;
Soo, Ross ;
Yong, Wei Peng .
INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (01) :169-176
[42]   Dose escalation for non-small cell lung cancer using conformal radiation therapy [J].
Robertson, JM ;
TenHaken, RK ;
Hazuka, MB ;
Turrisi, AT ;
Martel, MK ;
Pu, AT ;
Littles, JF ;
Martinez, FJ ;
Francis, IR ;
Quint, LE ;
Lichter, AS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (05) :1079-1085
[43]   A new approach to dose escalation in non-small-cell lung cancer [J].
Mehta, M ;
Scrimger, R ;
Mackie, R ;
Paliwal, B ;
Chappell, R ;
Fowler, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (01) :23-33
[44]   Response of global quality of life to high-dose palliative radiotherapy for non-small-cell lung cancer [J].
Schaafsma, J ;
Coy, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (03) :691-701
[45]   High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer [J].
De Ruysscher, Dirk ;
Faivre-Finn, Corinne ;
Le Pechoux, Cecile ;
Peeters, Stephanie ;
Belderbos, Jose .
LANCET ONCOLOGY, 2014, 15 (13) :E620-E624
[46]   Feasibility Study on the Central of Massive Lesion in Non-Small Cell Lung Cancer with High-Dose Radiotherapy [J].
Li, J. .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S1089-S1089
[47]   An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer [J].
Nieder, Carsten ;
Imingen, Kristian S. .
IN VIVO, 2021, 35 (02) :955-958
[48]   DEFINITIVE DOSE THORACIC RADIOTHERAPY IN OLIGOMETASTATIC STAGE IV NON-SMALL CELL LUNG [J].
Xanthopoulos, Eric P. ;
Fernandes, Annemarie T. ;
Griffith, Sandra ;
Apisarnthanarax, Smith ;
Christodouleas, John P. ;
Eaby-Sandy, Beth ;
Langer, Corey J. ;
Evans, Tracey ;
Stevenson, James ;
Hahn, Stephen ;
Rengan, Ramesh .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S612-S612
[49]   Dosimetric comparison of four radiotherapy techniques for stage III non-small cell lung cancer [J].
Li, Chao ;
Luo, Haifeng ;
Song, Wenli ;
Hu, Yan ;
Li, Jingjing ;
Cai, Zhiqiang .
ONCOLOGY LETTERS, 2023, 26 (02)
[50]   Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer [J].
Igari, Mitsunobu ;
Abe, Takanori ;
Iino, Misaki ;
Saito, Satoshi ;
Aoshika, Tomomi ;
Ryuno, Yasuhiro ;
Ohta, Tomohiro ;
Hirai, Ryuta ;
Kumazaki, Yu ;
Noda, Shin-ei ;
Kato, Shingo .
THORACIC CANCER, 2023, 14 (26) :2642-2647